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PCardiac Imaging
Assessment of Coronary Artery Disease
Using Magnetic Resonance Coronary Angiography
A National Multicenter Trial
Shingo Kato, MD,* Kakuya Kitagawa, MD,* Nanaka Ishida, MD,* Masaki Ishida, MD,*
Motonori Nagata, MD,* Yasutaka Ichikawa, MD,† Kazuhiro Katahira, MD,‡ Yuji Matsumoto, MD,§
Koji Seo, MD, Reiji Ochiai, MD,¶ Yasuyuki Kobayashi, MD,# Hajime Sakuma, MD*
Tsu, Matsusaka, Kumamoto, Saijyo, Utsunomiya, Kurume, and Kawasaki, Japan
Objectives This national multicenter study determined the diagnostic performance of 1.5-T whole-heart coronary magnetic
resonance angiography (MRA) in patients with suspected coronary artery disease (CAD).
Background Whole-heart coronary MRA using steady-state free precession allows noninvasive detection of CAD without the
administration of contrast medium. However, the accuracy of this approach has not been determined in a multi-
center trial.
Methods Using a 1.5-T magnetic resonance imaging unit, free-breathing steady-state free precession whole-heart coronary
MRA images were acquired for 138 patients with suspected CAD at 7 hospitals. The accuracy of MRA for detect-
ing a 50% reduction in diameter was determined using X-ray coronary angiography as the reference method.
Results Acquisition of whole-heart coronary MRA images was performed in 127 (92%) of 138 patients with an average
imaging time of 9.5  3.5 min. The areas under the receiver-operator characteristic curve from MRA images
according to vessel- and patient-based analyses were 0.91 (95% confidence interval [CI]: 0.87 to 0.95) and 0.87
(95% CI: 0.81 to 0.93), respectively. The sensitivity, specificity, positive and negative predictive values, and accu-
racy of MRA according to a patient-based analysis were 88% (49 of 56, 95% CI: 75% to 94%), 72% (51 of 71,
95% CI: 60% to 82%), 71% (49 of 69, 95% CI: 59% to 81%), 88% (51 of 58, 95% CI: 76% to 95%), and 79%
(100 of 127, 95% CI: 72% to 86%), respectively.
Conclusions Non–contrast-enhanced whole-heart coronary MRA at 1.5-T can noninvasively detect significant CAD with high sensi-
tivity and moderate specificity. A negative predictive value of 88% indicates that whole-heart coronary MRA can rule
out CAD. (J Am Coll Cardiol 2010;56:983–91) © 2010 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2010.01.071a
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woronary artery disease (CAD) is the most frequent cause
f death in developed countries (1), and the current gold
tandard for its detection is conventional X-ray coronary
ngiography (CAG). However, conventional CAG is ex-
ensive, potentially harmful, and associated with a small risk
f serious complications. In addition, a considerable number
f patients who undergo CAG have no evidence of clinically
mportant CAD. Coronary computed tomography angiog-
aphy is an inexpensive, noninvasive alternative to CAG for
uling out CAD. However, coronary computed tomography
rom the *Department of Radiology, Mie University Hospital, Tsu, Japan; †Depart-
ent of Radiology, Matsusaka Central Hospital, Matsusaka, Japan; ‡Department of
adiology, Kumamoto Central Hospital, Kumamoto, Japan; §Department of Cardiol-
gy, Saijyo Central Hospital, Saijyo, Japan; Department of Cardiology, Utsunomiya
entral Clinic, Utsunomiya, Japan; ¶Department of Radiology, Koga Hospital,
urume, Japan; and the #Department of Radiology, St. Marianna Hospital, Ka-
asaki, Japan. The authors have reported that they have no relationships to disclose.c
Manuscript received August 13, 2009; revised manuscript received December 1,
009, accepted January 6, 2010.ngiography still requires radiation exposure and an iodin-
ted contrast agent.
See page 992
Coronary magnetic resonance angiography (MRA) has
merged over the past decade as a possible noninvasive
lternative for visualizing coronary arteries (2). A previous
ulticenter study using a target volume, turbo field echo
ethod (3) showed that coronary MRA can reliably identify
eft main coronary artery (LM) stenosis or 3-vessel disease
3VD). Recently, steady-state free precession (SSFP)
hole-heart coronary MRA has become the method of
hoice for coronary imaging at 1.5-T (4–7). Because of an
ntrinsically high blood signal intensity (8), the SSFP
equence can acquire whole-heart coronary MRA images
ithout the need for magnetic resonance imaging (MRI)ontrast medium. Several single-center studies evaluated the
g
w
a
r
h
i
A
n
M
c
s
b
a
m
s
d
s
w
w
f
6
1
a
t
s
d
m
M
s
(
e
n
fi
2
1
u
r
M
e
W
a
c
R
p
u
i
u
e
b
a
e
a
v
l
i
P
984 Kato et al. JACC Vol. 56, No. 12, 2010
A National Multicenter Trial of 1.5-T Whole-Heart Coronary MRA September 14, 2010:983–91diagnostic performance of 1.5-T
SSFP whole-heart coronary MRA
for detecting significant coronary
artery stenoses on X-ray CAG
(9–11). However, to the best of
our knowledge, no multicenter
study has yet assessed the diag-
nostic value of 1.5-T whole-
heart coronary MRA.
Consequently, this multicenter
study determined the ability of
whole-heart coronary MRA to de-
tect significant obstructive CAD
using conventional X-ray CAG.
Methods
Patients. We studied 138 pa-
tients with suspected CAD who
presented with chest pain that
suggested newly developed or re-
current coronary artery stenosis
and were scheduled for X-ray
CAG at 7 hospitals during the
period August 2005 to December
2007. Exclusion criteria included
patients with general contraindica-
tions to MRI (e.g., pacemakers,
claustrophobia), acute coronary
syndrome, atrial fibrillation, and
previous coronary bypass graft sur-
ery. Table 1 summarizes the features of the 138 patients, of
hom 95 (69%) were male and 43 (31%) were female (mean
ge 67 9 years; range 39 to 87 years). The local institutional
eview board or local ethics committee of all participating
ospitals approved the study, and all patients gave written
nformed consent to participate.
cquisition of MRI data. We acquired magnetic reso-
ance (MR) images using a 1.5-T MRI unit (Intera, Philips
edical Systems, Best, the Netherlands) with a 5-channel
ardiac coil. Isosorbide dinitrate (5 mg) was administered
ublingually to the patients before undergoing MRI. Beta-
lockers were not used in this study. The tight-fitting
bdominal belt was wrapped in all patients to suppress the
otion of the diaphragm in relation to breathing. Initial
urvey images to determine the position of the heart and
iaphragm and reference images to evaluate individual coil
ensitivities for parallel imaging acquisition were obtained
ithout holding the breath. Transaxial cine MR images
ere then acquired with an SSFP sequence while breathing
reely (repetition time, 2.6 ms; echo time, 1.3 ms; flip angle,
0°; field of view, 320 320 120 mm; acquisition matrix,
28  128; cardiac phases, 50; SENSE factor, 3.0 in the
nteroposterior direction; imaging time, 3 s) to determine
he rest period of the right coronary artery (RCA). Patient-
Abbreviations
and Acronyms
3D  3-dimensional
3VD  3-vessel disease
AUC  area under the
receiver-operator
characteristic curve
BMI  body mass index
CAD  coronary artery
disease
CAG  coronary
angiography
CI  confidence interval
HR  heart rate
LM  left main coronary
artery
MDCT  multidetector-row
computed tomography
MR  magnetic resonance
MRA  magnetic
resonance angiography
MRI  magnetic resonance
imaging
NPV  negative predictive
value
PPV  positive predictive
value
RCA  right coronary
arterypecific acquisition windows were set during either the
Diastolic or systolic phase, depending on the phase of
inimal motion of the RCA.
Free-breathing, navigator-gated whole-heart coronary
R angiograms were obtained using a 3-dimensional (3D),
egmented SSFP sequence with radial k-space sampling
repetition time, 4.1 ms; echo time, 2.1 ms; flip angle, 80°;
xcitations per cardiac cycle, 20 to 50; SENSE factor, 2.0;
avigator gating window, 2.5 mm; no drift correction;
eld of view, 300  300  130 mm; acquisition matrices,
24  224  75; reconstruction matrices, 512  512 
50). Myocardial and venous blood signals were suppressed
sing T2 preparation. Spectral pre-saturation with inversion
ecovery was also applied to suppress epicardial fat signals.
RA data acquisition was terminated if the scan length
xceeded 30 min.
hole-heart coronary MRA analysis. Coronary MR im-
ges were transferred to a 3D PACS (picture archiving and
ommunication system) server (Aquarius NET server, Tera-
econ, Inc., San Mateo, California). Two observers inde-
endently evaluated the whole-heart coronary MRA images
sing sliding thin-slab maximum intensity projection. The
mage quality of whole-heart coronary MRA was evaluated
sing the following scale: 1, poor (coronary vessel barely
vident or noisy image); 2, moderate (coronary vessel visible
ut diagnostic confidence low); 3, good (coronary artery
dequately visualized and diagnostic quality image); and 4,
xcellent (coronary artery clearly depicted). Results gener-
ted by 2 readers were averaged. The coronary arteries were
isually screened for the presence or absence of significant
uminal narrowing (50% diameter reduction) using an
ntention-to-read approach. All coronary arteries were in-
atient CharacteristicsTable 1 Patient Characteristics
Characteristics
All Patients Who
Underwent
Coronary MRA
(n  138)
Patients With
Successful Acquisition of
Coronary MRA Images
(n  127)
Male/female 95/43 86/41
Age, yrs 67 9 67 9
Range 39–87 39–87
Heart rate, beats/min 68 12 68 12
Range 42–108 42–108
Body mass index, kg/m2 24 4 24 4
Previous myocardial infarction 30 (22) 28 (22)
Coronary stent 15 (11) 14 (11)
Risk factors
Hypertension 103 (75) 95 (75)
Hypercholesterolemia 64 (46) 61 (48)
Diabetes mellitus 46 (33) 41 (32)
Smoking 59 (43) 54 (43)
Family history of CAD 29 (21) 27 (21)
Stenosis on coronary angiography
1-vessel disease 41 (30) 41 (32)
2-vessel disease 12 (9) 11 (9)
3-vessel disease 4 (3) 4 (3)ata are expressed as mean  SD or n (%).
CAD  coronary artery disease; MRA  magnetic resonance angiography.
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September 14, 2010:983–91 A National Multicenter Trial of 1.5-T Whole-Heart Coronary MRAluded for the evaluation regardless the image quality of
oronary MRA to avoid overestimation of the diagnostic
ccuracy (12–14). Disagreement between the 2 observers
as settled by a consensus reading. For receiver-operator
haracteristic curve analysis, 2 observers visually graded the
ikelihood of coronary artery stenosis on whole-heart coro-
ary MR angiograms according to the following scale: 1,
bsent; 2, probably absent; 3, possibly present; 4, probably
resent; and 5, definitely present. Results for the 2 readers
ere averaged. The in-stent coronary lumen was not in-
luded in the analysis. To evaluate the impact of heart rate
HR) on image quality and diagnostic performance, the
atients were divided into 2 groups based on HR as follows:
roup 1, HR 70 beats/min (n  72, mean HR 60  7.0
eats/min, range 42 to 68 beats/min) and group 2, HR70
eats/min (n  55, mean HR 78  8.6 beats/min, range 70
o 108 beats/min). In addition, the impact of body mass
ndex (BMI) on diagnostic performance was evaluated. The
atients were divided into 2 groups based on BMI as
ollows: group 3, BMI 25 kg/m2 (n  83, mean BMI
2.0  2.2 kg/m2, range 15.8 to 24.8 kg/m2), and group 4,
MI 25 kg/m2 (n  44, mean BMI 27.5  2.4 kg/m2,
ange 25.1 to 40.4 kg/m2).
-ray CAG and interpretation. An observer who was
linded to the results of whole-heart coronary MRA inter-
reted the conventional X-ray coronary angiograms in
hich coronary artery stenosis was evaluated using quanti-
ative CAG software (QangioXA, Medis, Inc., Raleigh,
orth Carolina). Intracoronary administration of isosorbide
initrate (2 to 3 mg) was performed in all patients before
ontrast injection. Significant coronary arterial stenosis was
efined as a reduction in luminal diameter of 50%.
tatistical analysis. Based on the sensitivity of 82% and
pecificity of 90% in a patient-based analysis in a previous
ingle-center study that assessed 113 patients with the preva-
ence of 45% (9), we estimated that a minimum of 127 subjects
ere required to reject the null hypothesis that either sensitivity
r specificity is 70% with a p value 0.05.
The diagnostic accuracy of MRA was determined for
esions with a reference diameter of 2.0 mm on X-ray
oronary angiograms regardless of the quality of images
cquired from patients for whom MRI was completed. Data
n subjects with successful MRA acquisitions (92%) under-
ent statistical analysis using SPSS software, version 11.5
SPSS, Inc., Chicago, Illinois). Areas under receiver-
perator characteristic curves were calculated to evaluate the
iagnostic performance of whole-heart coronary MRA.
ontinuous values are presented as mean  SD. Because
he image quality score comprised skewed variables (accord-
ng to the Shapiro-Wilk test), the differences between image
uality scores of 2 groups were tested using the Mann-
hitney U test. The correlation between image quality
core and HR and the level of agreement between the 2
aters with respect to the 5-point scale ratings for receiver-
perator characteristic analysis were evaluated using Spear-
an’s rank correlation. Sensitivity, specificity, positive pre- 0ictive value (PPV), negative predictive value (NPV), and
ccuracy per patient, vessel, and segment analysis were
alculated with a 95% confidence interval (CI). The level
f agreement between the 2 raters with respect to the
inary judgments was evaluated by the kappa value. The
ignificance of differences in diagnostic performance
etween patients with an HR of 70 and 70 beats/min
r a BMI 25 and 25 kg/m2 was tested using the
hi-square test for comparisons of cross tables. The
umber of subjects in whom the MR study could not be
ompleted was not taken into account in the calculation
f diagnostic performance. A p value 0.05 was consid-
red statistically significant.
esults
cquisition of whole-heart coronary MRA was completed
n 127 (92%) of 138 patients with an average imaging time
f 9.5  3.5 min (range 2.4 to 19.2 min). The total study
ime including the pre-scan was 30 min in patients
ndergoing a successful study. The mean  SD navigator
fficiency was 37.4  26.0%. Eleven patients for whom
RA images could not be acquired had an irregular
reathing pattern or the position of the diaphragm drifted
uring the procedure. The average HR in the 138 patients
as 68  12 beats/min. Whole-heart coronary MRA was
erformed during diastole in 73% (93 of 127) (mean HR
5 10 beats/min; mean acquisition window 131 40 ms;
ean imaging time 9.5  3.7 min) and during systole in
7% (34 of 127) (mean HR 76  13 beats/min; mean
cquisition window 110 52 ms; mean imaging time 9.2
.9 min) of the patients. Significant coronary artery stenosis
as observed on X-ray coronary angiograms from 56 (44%)
f the 127 patients in whom MR acquisition was completed.
mage quality of whole-heart coronary MRA. Table 2
ummarizes image quality scores in each coronary artery
egment of whole-heart coronary MRA. No significant
ifferences were found in the image quality scores between
roups 1 and 2 (HR 70 and 70 beats/min, respectively)
nd in any segment (p values ranged from 0.06 to 0.98).
mage quality scores did not significantly correlate with HR
Spearman’s rank correlation: r  0.04, p  0.65).
iagnostic accuracy of whole-heart coronary MRA. In a
atient-based analysis, the area under the receiver-operator
haracteristic curve (AUC) of whole-heart coronary MRA
as 0.87 (95% CI: 0.81 to 0.93) (Fig. 1) for the detection of
ignificant coronary artery stenoses on X-ray angiography.
he sensitivity, specificity, PPV, NPV, and accuracy for
etecting patients with significant CAD were 88% (95% CI:
5% to 94%), 72% (95% CI: 60% to 82%), 71% (95% CI:
9% to 81%), 88% (95% CI: 76% to 95%), and 79% (95%
I: 72% to 86%), respectively (Table 3). The kappa value
or the binary judgment was 0.73 (95% CI: 0.62 to 0.85) in
he patient-based analysis. In a vessel-based analysis, the
UC of whole-heart coronary MRA was 0.91 (95% CI:
.87 to 0.95) with Spearman’s rank correlation coefficient
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pecificity, PPV, NPV, and accuracy for detecting signifi-
ant coronary artery stenosis were 83% (95% CI: 72% to
0%), 90% (95% CI: 86% to 93%), 67% (95% CI: 57% to
7%), 96% (95% CI: 92% to 98%), and 89% (95% CI: 86%
Impact of High Heart Rate on Image Quality ScoTable 2 Impact of High Heart Rate on Imag
Artery
No. of Segments
>2.0 mm
All Patients
(n  127)
H
RCA
1 127 3.8 0.3
2 126 3.7 0.4
3 123 3.7 0.4
4 106 3.1 0.6
LM
5 127 3.8 0.3
LAD
6 123 3.7 0.4
7 127 3.6 0.5
8 127 3.1 0.7
9 111 2.6 0.8
LCX
11 127 3.4 0.5
12 112 2.4 0.8
13 125 3.2 0.7
Data are expressed as mean  SD. *p values represent significance
patients with heart rates of 70 and 70 beats/min.
HR heart rate; LAD left anterior descending artery; LCX left cir
artery; other abbreviation as in Table 1.
Figure 1
Receiver-Operator Characteristic
Curves of 1.5-T Whole-Heart Coronary MRA for
Detecting Significant Coronary Artery Stenosis
The area under the receiver-operator characteristic curve of 1.5-T non–contrast-
enhanced whole-heart coronary magnetic resonance angiography (MRA) for
detecting significant coronary artery disease is 0.87 (95% confidence interval
[CI]: 0.81 to 0.93), 0.91 (95% CI: 0.87 to 0.95), and 0.91 (95% CI: 0.87 to
0.95) in patient-, vessel-, and segment-based analyses, respectively.so 92%), respectively (Table 3). The kappa value for the
inary judgment was 0.79 (95% CI: 0.72 to 0.87) in the
essel-based analysis. The individual AUC for the RCA,
he left anterior descending artery including the LM and left
ircumflex artery were 0.91 (95% CI: 0.84 to 0.98), 0.92
95% CI: 0.87 to 0.97), and 0.87 (95% CI: 0.75 to 0.99),
espectively (Fig. 2). Spearman’s rank correlation coefficient
etween the 2 readers was 0.85 in a patient-based analysis.
he mean  SD rating for positive consensus judgments
as 2.56  0.17. There were 3 segments for the negative
onsensus judgment and the mean  SD MR rating was
.00  0.00. The sensitivity, specificity, PPV, NPV, and
ccuracy of whole-heart coronary MRA for detecting LM
tenosis or 3VD were 89% (95% CI: 51% to 99%), 100%
95% CI: 96% to 100%), 100% (95% CI: 60% to 100%),
9% (95% CI: 95% to 100%), and 99% (95% CI: 98% to
00%). Figures 3 and 4 illustrate the detection of significant
tenoses by whole-heart coronary MRA with correlation
ith X-ray CAG.
mpact of HR on diagnostic performance of whole-heart
oronary MRA. Table 4 summarizes the diagnostic per-
ormance of whole-heart coronary MRA in patients with an
R 70 beats/min and those with an HR 70 beats/min.
he sensitivity, specificity, PPV, and NPV did not signifi-
antly differ between the 2 groups at any level of analysis
patient, vessel, and segment).
mpact of BMI on diagnostic performance of whole-
eart coronary MRA. Table 5 summarizes the diagnostic
erformance of whole-heart coronary MRA in patients with
BMI 25 kg/m2 and those with a BMI 25 kg/m2. No
Whole-Heart Coronary MRAlity Score of Whole-Heart Coronary MRA
ients With
0 beats/min
 72)
Patients With
HR >70 beats/min
(n  55) p Value*
.8 0.4 3.7 0.3 0.08
.8 0.4 3.7 0.4 0.06
.7 0.4 3.7 0.4 0.55
.1 0.7 3.2 0.5 0.6
.8 0.3 3.8 0.3 0.98
.7 0.4 3.6 0.5 0.53
.6 0.5 3.5 0.5 0.40
.2 0.7 3.1 0.7 0.47
.7 0.7 2.5 0.9 0.23
.4 0.6 3.4 0.5 0.67
.3 0.8 2.4 0.8 0.76
.3 0.7 3.2 0.7 0.38
rence in image quality score of whole-heart coronary MRA between
coronary artery; LM left main coronary artery; RCA right coronaryre ofe Qua
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77% vs. 55%, p  0.03).
iscussion
he present prospective, multicenter trial evaluated the
iagnostic ability of non–contrast-enhanced whole-heart
oronary MRA to detect significant coronary artery stenosis
n X-ray CAG among patients with suspected CAD. We
pplied an intention-to-read approach without excluding
egments with low image quality (12–14). Whole-heart
oronary MRA demonstrated high sensitivity (88%), mod-
rate specificity (72%), a moderate PPV (71%), and a high
PV (88%) with an AUC of 0.87 for detecting significant
oronary artery stenosis. An NPV of 88% indicated that
hole-heart coronary MRA is useful for ruling out CAD in
iagnostic Accuracy of Whole-Heart Coronary MRA Compared WithTable 3 Diagnostic Accuracy of Whole-Heart Coronary MRA Co
n Sensitivity Specificity
Per patient 127 88 (49/56) [75–94] 72 (51/71) [60–82]
Per vessel 381 83 (62/75) [72–90] 90 (276/306) [86–93]
RCA 127 77 (17/22) [54–91] 90 (95/105) [83–95]
LM 127 100 (6/6) [52–100] 100 (121/121) [96–100]
LAD 127 91 (32/35) [76–98] 82 (75/92) [72–89]
LCX 127 69 (11/16) [42–88] 97 (108/111) [92–99]
Per segment 1,461 81 (73/90) [71–88] 98 (1,341/1,371) [97–99]
alues are shown as percentages. Data are % (raw data) [95% confidence interval].
CI  confidence interval; NPV  negative predictive value; PPV  positive predictive value; oth
Figure 2 Receiver-Operator Characteristic Curves of 1.5-T
Whole-Heart Coronary MRA for Individual Vessels
The area under the receiver-operator characteristic curve of 1.5-T non–contrast-
enhanced whole-heart coronary MRA for detecting significant coronary artery
disease is 0.91 (95% CI: 0.87 to 0.95) for all 3 vessels, 0.91 (95% CI: 0.84
to 0.98) for the right coronary artery (RCA), 0.92 (95% CI: 0.87 to 0.97) for the
left anterior descending artery (LAD) (including the left main coronary artery),
and 0.87 (95% CI: 0.75-0.99) for the left circumflex artery (LCX). Abbreviations
as in Figure 1.natients with suspected CAD and is thus useful for elimi-
ating unnecessary X-ray CAG. In addition, a high NPV of
9% for detecting LM stenosis or 3VD was observed in the
urrent multicenter study. Therefore, 1.5-T whole-heart
oronary MRA reliably rules out LM stenosis or 3VD.
Until the development of the whole-heart approach,
oronary MRA was performed by repeated acquisitions of a
argeted volume of 3-cm thickness using a double oblique,
D gradient echo sequence. One prospective multicenter
tudy revealed that 3D coronary MRA using a gradient echo
equence and a target volume approach can accurately
dentify LM stenosis or 3VD. However, the clinical utility
f target volume coronary MRA is limited by time-
onsuming 3-point planning, lengthy scanning time (70
in on average), and poor specificity (42%) when all vessels
re analyzed (3).
The introduction of SSFP sequences allowed acquisition
f a large 3D volume covering the entire heart without
ompromising the high blood signal of coronary arteries.
lanning of the 3D volume for whole-heart coronary MRA
s quite simple, and considerable time can be gained by
liminating 3-point planning. One study demonstrated that
hole-heart coronary MRA can be performed in 30 min
7). The diagnostic accuracy of SSFP whole-heart coronary
RA was evaluated by several single-center studies (9–11),
n which the sensitivity and specificity of whole-heart
oronary MRA ranged from 78% to 96% and from 68% to
6%, respectively, for significant CAD. The sensitivity and
pecificity demonstrated in the current study are in line with
hese published results from single-center studies.
The use of a patient-specific acquisition window in the
ardiac cycle can provide optimal temporal resolution for
ach patient, allowing the acquisition of diagnostic coronary
R images without the administration of beta-blockers,
ven in patients with a high HR (70 beats/min). This is
ne advantage of whole-heart coronary MRA over multi-
etector computed tomography (MDCT) of coronary ar-
eries in which a lower HR is often essential for high-quality
mages. In addition, whole-heart coronary MRA does not
equire exposure to ionizing radiation or the injection of
odinated contrast material, and high-density calcium does
iographic Angiographyed With Radiographic Angiography
PPV NPV Accuracy
(49/69) [59–81] 88 (51/58) [76–95] 79 (100/127) [72–86]
(62/92) [57–77] 96 (276/289) [92–98] 89 (338/381) [86–92]
(17/27) [43–80] 95 (95/100) [88–98] 88 (112/127) [83–94]
(6/6) [52–100] 100 (121/121) [96–100] 100 (127/127) [—]
(32/49) [50–78] 96 (75/78) [88–99] 84 (107/127) [78–91]
(11/14) [49–94] 96 (108/113) [90–98] 94 (119/127) [90–98]
(73/103) [61–79] 99 (1,341/1,358) [98–99] 97 (1,414/1,461) [96–98]
viations as in Tables 1 and 2.Radmpar
71
67
63
100
65
79
71ot cause beam-hardening artifacts (15).
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alues of 64-row MDCT angiography for detecting signif-
cant coronary artery stenosis are 0.93 and 0.91 in patient-
nd vessel-based analyses, respectively (16). These AUC
alues are slightly higher than those of whole-heart coronary
RA in the current study. However, several patients (22%
f entire study population) had to be excluded from the
nalysis in that MDCT multicenter trial due to heavy
oronary calcification. Another prospective multicenter trial
sing 64-row MDCT showed sensitivity of 95%, specificity
f 83%, a PPV of 64%, and an NPV of 99% for detecting
uminal diameter narrowing of 50% on invasive coronary
ngiograms (17). The NPV of 88% in this multicenter study
as lower than that of 64-row MDCT. However, whole-
eart coronary MRA can overcome heavy coronary arterial
alcification and achieve sufficient diagnostic performance
ithout the use of contrast medium and ionizing radiation.
n this regard, 1.5-T whole-heart coronary MRA is prefer-
ble in patients with lower pretest probability of CAD
Figure 3 Noncontrast-Enhanced 1.5-T Whole-Heart Coronary MR
Sliding thin-slab maximum intensity projection image (A) and volume-rendered ima
(arrow). Curved planar reconstruction image shows severe coronary artery stenosi
X-ray coronary angiography (D). Black arrowhead in D indicates coronary artery ste
branch. AO  aorta; other abbreviations as in Figures 1 and 2.ompared with 64-row MDCT. rContrast-enhanced whole-heart coronary MRA at
.0-T has emerged as a means of improving the contrast-
o-noise ratio compared with noncontrast-enhanced
.5-T whole-heart coronary MRA (18,19). The diagnos-
ic accuracy of 3.0-T contrast-enhanced whole-heart
oronary MRA was recently evaluated in 69 patients with
uspected CAD in a single-center trial (20). Although
he acquisition time (9.0  1.9 min) and study success
ate (89.9%) were similar to those of our current study,
he diagnostic performance of 3.0-T whole-heart coro-
ary MRA seems to be quite promising, with 94.1%
ensitivity and 82.1% specificity for detecting 50%
tenoses in the coronary arteries. However, due to in-
reased field inhomogeneity and radiofrequency energy
eposition at a high field strength, 3.0-T whole-heart
oronary MRA relies on a double-dose infusion of a
igh-relaxivity contrast medium. The use of contrast
edium increases the study cost and is associated with
otential side effects, especially in patients with impaired
a 58-Year-Old Man Presenting With Chest Pain on Effort
detect coronary artery stenoses in the LAD (arrowhead) and diagonal branch
e LAD (C, arrowhead). Good agreement is observed between coronary MRA and
in the LAD; black arrow in D indicates coronary artery stenosis in the diagonalA in
ge (B)
s in th
nosisenal function. Therefore, non– contrast-enhanced 1.5-T
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ompeting modalities and may have different indications.
tudy limitations. Our study population had a clinical
ndication for X-ray CAG and thus had a disease prevalence
f 44%. Although 1.5-T whole-heart coronary MRA is a
oninvasive examination with an NPV of 88%, as demon-
trated here, this technology should not be considered for
opulations with a low prevalence of CAD (e.g., screening
AD in asymptomatic patients) at this time. The PPV,
Figure 4 Noncontrast-Enhanced 1.5-T Whole-Heart Coronary MR
Significant coronary artery stenosis in the LCX (white arrowhead) is observed in t
image (B), and the curved planar reconstruction image (C), with good correlati
Figures 1, 2, and 3.
mpact of HR on Diagnostic Performance of Whole-Heart CoronaryTable 4 Impact of HR on Diagnostic Performance of Whole-Hea
n Sensitivity Specific
HR 70 beats/min
Patient-based analysis 72 85 (29/34) [68–98] 74 (28/38) [5
Vessel-based analysis 216 77 (34/44) [62–88] 91 (157/172)
Segment-based analysis 831 76 (42/55) [63–86] 98 (761/776)
HR 70 beats/min
Patient-based analysis 55 91 (20/22) [69–98] 70 (23/33) [5
Vessel-based analysis 165 90 (28/31) [73–98] 89 (119/134)
Segment-based analysis 630 89 (31/35) [72–96] 97 (580/595)alues are shown as percentages. Data are % (raw data) [95% confidence interval].
AUC  area under the receiver-operator characteristic curve; other abbreviations as in Tables 2 and 3.hich was 71% in the current patient population with a
oderate to high pretest probability of CAD, will be
educed in individuals with low pretest probabilities. There-
ore, screening asymptomatic individuals by coronary MRA
ould increase the potential for performing unnecessary
oronary computed tomography angiography and/or CAG
nd incurring additional costs. MR images could not be
cquired in approximately 8% of the patients. Because this
as due to unstable breathing patterns or drift of the
a 66-Year-Old Woman
ding thin-slab maximum intensity projection image (A), the volume-rendered
h X-ray coronary angiography (black arrowhead) (D). Abbreviations as in
ronary MRA
PPV NPV AUC
74 (29/39) [58–86] 85 (28/33) [67–94] 0.90 [0.83–0.97]
5] 69 (34/49) [54–81] 94 (157/167) [90–97] 0.89 [0.82–0.95]
9] 74 (42/57) [60–84] 98 (761/774) [97–99] 0.89 [0.83–0.95]
67 (20/30) [47–82] 92 (23/25) [72–99] 0.87 [0.78–0.96]
3] 65 (28/43) [49–79] 98 (119/122) [92–99] 0.94 [0.90–0.98]
9] 67 (31/46) [52–80] 99 (580/584) [98–100] 0.94 [0.89–1.00]A in
he sli
on witMRArt Co
ity
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A National Multicenter Trial of 1.5-T Whole-Heart Coronary MRA September 14, 2010:983–91iaphragm position during the scan, the study success rate
hould be improved if imaging time can be reduced. The
erformance of whole-heart coronary MRA using 32-
hannel cardiac coils and a higher parallel imaging factor is
urrently under investigation from this perspective. Asian
ndividuals were studied in this national multicenter study.
ue to the lack of a large population study in the Asian
ountries including Japan, pretest probability of CAD was
ifficult to estimate in the patient group that we studied. In
ddition, the BMI of the patient population (average BMI
24  4 kg/m2) was relatively low for patients with CAD
n a Western population. When we analyzed the impact of
MI on diagnostic performance of whole-heart coronary
RA, the AUC of 1.5-T whole-heart coronary MRA for
etecting significant CAD was similar between the 2 groups
BMI25 and25 kg/m2) at any level of analysis (patient,
essel, and segment). However, it should be noted that the
PV in a segment-based analysis was significantly lower in
atients with a BMI 25 kg/m2 than in those with a BMI
25 kg/m2, indicating that the diagnostic performance of
oronary MRA is significantly influenced by BMI. For ruling
ut significant CAD, the NPV in a patient-based analysis was
9% in patients with a BMI 25 kg/m2 and 87% in patients
ith a BMI25 kg/m2. For the prediction of LM stenosis or
VD, the NPV was 99% in patients with a BMI 25 kg/m2
nd 100% in patients with a BMI 25 kg/m2 in this study
opulation. These results suggest that whole-heart coronary
RA is of value for noninvasive exclusion of significant CAD
egardless of BMI. We used SENSE factor of 3 in the
nteroposterior direction in all patients. In patients with higher
MIs, the imaging time of cine MRI to determine the rest
eriod of the RCA may be increased from 3 s to 5 s using a
educed SENSE factor of 2. However, a slightly increased
maging time does not seem to become a major limitation in
ssessing the rest period of the RCA. A previous study by
ahnke et al. (21) demonstrated that radial k-space sampling
eads to small vessel diameters in the images compared with
artesian sampling. We did not compare vessel diameter
etween whole-heart coronary MRA and X-ray CAG in this
tudy. Further study is required to determine the accuracy of
RA with radial k-space sampling for the measurement of
essel diameter. The current whole-heart coronary MRA
mpact of BMI on Diagnostic Performance of Whole-Heart CoronaryTable 5 Impact of BMI on Diagnostic Performance of Whole-He
n Sensitivity Specifi
BMI 25 kg/m2
Patient-based analysis 83 90 (37/41) [76–97] 74 (31/42) [5
Vessel-based analysis 249 85 (47/55) [73–93] 91 (177/194
Segment-based analysis 955 84 (57/68) [72–91] 98 (870/887
BMI 25 kg/m2
Patient-based analysis 44 80 (12/15) [51–95] 69 (20/29) [4
Vessel-based analysis 132 75 (15/20) [51–90] 88 (99/112)
Segment-based analysis 506 73 (16/22) [50–88] 97 (471/484
alues are shown as percentages. Data are % (raw data) [95% confidence interval].
BMI  body mass index; other abbreviations as in Tables 1, 3, and 4.pproach is optimized for assessing luminal stenoses in theoronary arteries and does not provide sufficient information
egarding the presence and characteristics of atherosclerotic
laque in the coronary arterial wall.
onclusions
hole-heart coronary MRA noninvasively detected signif-
cant coronary artery stenosis with sensitivity of 88% and
pecificity of 72% in this multicenter trial. An NPV of 88%
n a patient-based analysis indicates the potential role of
hole-heart coronary MRA to rule out CAD in patients
ith chest pain. In addition, 1.5-T whole-heart coronary
RA reliably rules out LM stenosis or 3VD with a high
PV of 99%.
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